Pcsk 9 Sirna denied for failing step therapy by Cigna?

Cigna's specific coverage criteria for pcsk9 sirna are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied This Claim — and Why You Can Appeal

Cigna's step-therapy denial for a PCSK9 siRNA therapy means Cigna requires documented trials and failures of one or more preferred or lower-cost alternatives before approving the prescribed agent. Step-therapy protocols for lipid-lowering therapy are common and often require trials of high-intensity statins and/or other agents first. However, step-therapy requirements are frequently waivable when prior trials are already documented, when prior agents caused clinically documented adverse effects, or when the patient's clinical profile makes prior-step agents inappropriate. Many states also have step-therapy override laws; check whether your state's law applies to your plan type.

## Your Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA §2719): File a written internal appeal within the deadline on your denial notice. ERISA requires a full-and-fair review that includes clinical evaluation of the step-therapy exception criteria.
• Step-therapy exception request: Before or alongside the formal appeal, ask Cigna in writing for its step-therapy exception criteria. Most plans must grant an exception when prior steps have been tried and failed, are contraindicated per the prescriber's clinical judgment, or would cause harm.
• External review (ACA §2719): After final internal denial, you have approximately four months to file with an independent review organization.
• Expedited option: Available when delay would seriously jeopardize health.

## Documentation to Gather

1. Complete prior-therapy history — for each drug Cigna's step-therapy protocol requires, provide: drug name, start date, end date, dose from chart (as prescribed), and the documented clinical reason the trial ended (side effects, lab findings, inadequate response — all from chart notes). 2. Prescriber's medical-necessity letter — your cardiologist or internist should address each step in Cigna's protocol directly, explaining why the prescribed PCSK9 siRNA is now appropriate and why prior steps are inadequate or have been exhausted. 3. Clinical severity documentation — chart notes, specialist evaluations, and any documented cardiovascular events or risk factors relevant to urgency. 4. Applicable guideline reference — cite the relevant ACC/AHA or other applicable cardiovascular guideline organization (without quoting specific numbers) to support the prescriber's clinical reasoning. 5. State step-therapy override law — if your state has one and it applies to your plan, cite it explicitly in your appeal.

## Criteria-Mapping Structure for Your Appeal Letter

| Step-therapy requirement (from Cigna's policy) | Chart-based response | |---|---| | Trial of [required agent 1] | Dates, chart documentation, reason discontinued | | Trial of [required agent 2] | Dates, chart documentation, reason discontinued | | Exception basis: adverse effect / contraindication | Prescriber clinical narrative + chart note | | Exception basis: clinical urgency | Documentation of severity and risk |

If Cigna denies the step-therapy exception, the external reviewer will independently assess whether Cigna's protocol is consistent with generally accepted standards of care — giving you a meaningful second look.